A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.
Clinical trial NCT00461058 · COMPLETED
Trial details
- NCT number
- NCT00461058
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2007-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.